» Articles » PMID: 26852221

Optic Toxicity in Radiation Treatment of Meningioma: a Retrospective Study in 213 Patients

Overview
Journal J Neurooncol
Publisher Springer
Date 2016 Feb 8
PMID 26852221
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

In this retrospective evaluation, we correlated radiation dose parameters with occurrence of optical radiation-induced toxicities. 213 meningioma patients received radiation between 2000 and 2013. Radiation dose and clinical data were extracted from planning systems and patients' files. The range of follow-up period was 2-159 months (median 75 months). Median age of patients was 60 years (range 23-86). There were 163 female and 50 male patients. In 140 cases, at least one of the neuro-optic structures (optic nerves and chiasm) was inside the irradiated target volumes. We found 15 dry eye (7 %) and 24 cataract (11.2 %) cases. Median dose to affected lachrymal glands was 1.47 Gy and median dose to affected lenses was 1.05 Gy. Age and blood cholesterol level in patients with cataract were significantly higher. Patients with dry eye were significantly older. Only two patients with visual problems attributable to radiation treatment were seen. They did not have any risk factors. Maximum and median delivered doses to neuro-optic structures were not higher than 57.30 and 54.60 Gy respectively. Low percentages of cases with radiation induced high grade optic toxicities show that modern treatment techniques and doses are safe. In very few patients with optic side effects, doses to organs at risk were higher than the defined constraint doses. This observation leads to the problem of additional risk factors coming into play. The role of risk factors and safety of higher radiation doses in high grade meningiomas should be investigated in more comprehensive studies.

Citing Articles

Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma.

Lee G, Aitelli A, Niemierko A, Lamba N, Kim D, Curry W Adv Radiat Oncol. 2025; 10(3):101726.

PMID: 40034477 PMC: 11872651. DOI: 10.1016/j.adro.2025.101726.


Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review.

Kinaci-Tas B, Alderliesten T, Verbraak F, Rasch C Cancers (Basel). 2023; 15(7).

PMID: 37046660 PMC: 10093581. DOI: 10.3390/cancers15071999.


Treatment of Recurrent Optic Nerve Sheath Meningioma With a Secondary Course of Radiotherapy.

Sharieff J, Melson A, Algan O Cureus. 2021; 13(9):e17935.

PMID: 34660125 PMC: 8513540. DOI: 10.7759/cureus.17935.


Loosening Neuro-Optic Structures Dosimetric Constraints Provides High 5-Year Local Recurrence-Free Survival With Acceptable Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy.

Zhang T, Xu M, Mi J, Yang H, Liu Z, Huang L Front Oncol. 2021; 11:598320.

PMID: 33692949 PMC: 7937960. DOI: 10.3389/fonc.2021.598320.


Late effects of cancer treatment: consequences for long-term brain cancer survivors.

Alemany M, Velasco R, Simo M, Bruna J Neurooncol Pract. 2021; 8(1):18-30.

PMID: 33664966 PMC: 7906268. DOI: 10.1093/nop/npaa039.


References
1.
Martel M, Sandler H, Cornblath W, Marsh L, Hazuka M, Roa W . Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors. Int J Radiat Oncol Biol Phys. 1997; 38(2):273-84. DOI: 10.1016/s0360-3016(97)00029-1. View

2.
Khoo V, Oldham M, Adams E, Bedford J, Webb S, Brada M . Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys. 1999; 45(2):415-25. DOI: 10.1016/s0360-3016(99)00213-8. View

3.
Gordon K, Char D, Sagerman R . Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys. 1995; 31(5):1123-39. DOI: 10.1016/0360-3016(95)00062-4. View

4.
Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J . Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys. 2007; 68(3):858-63. DOI: 10.1016/j.ijrobp.2006.12.073. View

5.
Parsons J, Bova F, Mendenhall W, Million R, Fitzgerald C . Response of the normal eye to high dose radiotherapy. Oncology (Williston Park). 1996; 10(6):837-47; discussion 847-8, 851-2. View